China — The Supply-Chain Chapter
The world's bulk peptide/API manufacturing hub; export-driven, and domestic rules are not the export reality. CBP seized roughly 130,000 vials nationa
The world’s bulk peptide/API manufacturing hub; export-driven, and domestic rules are not the export reality. CBP seized roughly 130,000 vials nationally (Oct 2025–Aug 2026); a 20-state attorneys-general letter (Sep 18, 2026) pressed for Green List expansion against Chinese suppliers; the Utah physician indictment (April 2026, allegation only) alleges Chinese-sourced product for 200+ patients. One creator in our library filmed buying peptides in China — a first-person account, filed as a video page, never as a how-to. We name no suppliers and publish no ordering detail. Ever.
Country posture summarized from our November 7, 2026 census research (regulator-sourced where available; some country detail remains unverified and is flagged as such in the census). Global baseline: no regulator in our 28-country set has approved BPC-157 or TB-500 as a medicine.
Educational information only — not medical or legal advice. Status as of November 7, 2026. See Our Legal Mandate.